Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Apr 11:14:345.
doi: 10.1186/1471-2458-14-345.

Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial

Lijing L Yan, Weigang Fang, Elizabeth Delong, Bruce Neal, Eric D Peterson, Yining Huang, Ningling Sun, Chen Yao, Xian Li, Stephen MacMahon, Yangfeng Wu  1
Affiliations
Randomized Controlled Trial

Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial

Lijing L Yan et al. BMC Public Health. .

Abstract

Background: The high-risk strategy has been proven effective in preventing cardiovascular disease; however, the population benefits from these interventions remain unknown. This study aims to assess, at the population level, the effects of an evidence-based high cardiovascular risk management program delivered by village doctors in rural China.

Methods: The study will employ a cluster-randomized controlled trial in which a total of 120 villages in five northern provinces of China, will be assigned to either intervention (60 villages) or control (60 villages). Village doctors in intervention villages will be trained to implement a simple evidence-based management program designed to identify, treat and follow-up as many as possible individuals at high-risk of cardiovascular disease in the village. The intervention will also include performance feedback as well as a performance-based incentive payment scheme and will last for 2 years. We will draw two different (independent) random samples, before and after the intervention, 20 men aged≥50 years and 20 women aged≥60 years from each village in each sample and a total of 9,600 participants from 2 samples to measure the study outcomes at the population level. The primary outcome will be the pre-post difference in mean systolic blood pressure, analyzed with a generalized estimating equations extension of linear regression model to account for cluster effect. Secondary outcomes will include monthly clinic visits, provision of lifestyle advice, use of antihypertensive medications and use of aspirin. Process and economic evaluations will also be conducted.

Discussion: This trial will be the first implementation trial in the world to evaluate the population impact of the high-risk strategy in prevention and control of cardiovascular disease. The results are expected to provide important information (effectiveness, cost-effectiveness, feasibility and acceptability) to guide policy making for rural China as well as other resource-limited countries.

Trial registration: The trial is registered at ClinicalTrials.gov (NCT01259700). Date of initial registration is December 13, 2010.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Management algorithm for the identification, management, and follow-up of high-risk patients.
See this image and copyright information in PMC

References

    1. Lozano R, Ahn SY, Ohno SL, Alvarado M, Anderson HR, Anderson LM, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M. et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
    1. Vos T, Aboyans V, Dherani M, Abraham J, Ackerman I, Aggarwal R, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D. et al.Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163. doi: 10.1016/S0140-6736(12)61729-2. - DOI - PMC - PubMed
    1. Global status report on noncommunicable disease 2010: Description of the global burden of NCDs, their risk factors and determinants. World Health Organisation; 2010. April 2011. http://www.who.int/nmh/publications/ncd_report2010/en/. Accessed April 2014.
    1. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press; 1992.
    1. Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits?Yes. BMJ. 2008;337:a1371. doi: 10.1136/bmj.a1371. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources